Overview
Gul Bahtiyar is an Endocrinologist in Brooklyn, New York. Dr. Bahtiyar is rated as an Advanced provider by MediFind in the treatment of Hypercalcemia. Her top areas of expertise are Hyperthyroidism, Graves Disease, Hypercalcemia, and Milk-Alkali Syndrome.
Her clinical research consists of co-authoring 16 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
Additional Areas of Focus
Dr. Bahtiyar has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Trustees Of Columbia University In The City Of New York
John Bilezikian is an Endocrinologist in New York, New York. Dr. Bilezikian is rated as an Elite provider by MediFind in the treatment of Hypercalcemia. His top areas of expertise are Hyperparathyroidism, Hypoparathyroidism, Hypercalcemia, Parathyroidectomy, and Hormone Replacement Therapy (HRT).
North Shore-Lij Medical PC
Natalie Cusano is an Endocrinologist in New York, New York. Dr. Cusano is rated as an Elite provider by MediFind in the treatment of Hypercalcemia. Her top areas of expertise are Hypoparathyroidism, Hyperparathyroidism, Postmenopausal Osteoporosis, Parathyroidectomy, and Hormone Replacement Therapy (HRT).
Trustees Of Columbia University In The City Of New York
Shonni Silverberg is an Endocrinologist in New York, New York. Dr. Silverberg is rated as a Distinguished provider by MediFind in the treatment of Hypercalcemia. Her top areas of expertise are Hyperparathyroidism, Osteoporosis, Postmenopausal Osteoporosis, Hypercalcemia, and Parathyroidectomy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Graves DiseaseDr. Bahtiyar isAdvanced. Learn about Graves Disease.
- HypercalcemiaDr. Bahtiyar isAdvanced. Learn about Hypercalcemia.
- HyperthyroidismDr. Bahtiyar isAdvanced. Learn about Hyperthyroidism.
- HypothyroidismDr. Bahtiyar isAdvanced. Learn about Hypothyroidism.
- Milk-Alkali SyndromeDr. Bahtiyar isAdvanced. Learn about Milk-Alkali Syndrome.
- Experienced
- Congenital Adrenal Hyperplasia (CAH)Dr. Bahtiyar isExperienced. Learn about Congenital Adrenal Hyperplasia (CAH).
- Cushing's syndromeDr. Bahtiyar isExperienced. Learn about Cushing's syndrome.
- HyperparathyroidismDr. Bahtiyar isExperienced. Learn about Hyperparathyroidism.
- MalnutritionDr. Bahtiyar isExperienced. Learn about Malnutrition.
- Maturity Onset Diabetes of the YoungDr. Bahtiyar isExperienced. Learn about Maturity Onset Diabetes of the Young.
- Neuroendocrine TumorDr. Bahtiyar isExperienced. Learn about Neuroendocrine Tumor.